Pérez-Vera P, Montero-Ruíz O, Paredes-Aguilera R, Romero-Guzmán L

Language: Spanish
References: 4
Page: 181-182
PDF size: 47.74 Kb.

Text Extraction

No abstract

REFERENCES

1. Forestier E, Heim S, Blennow E, Borgstrom G, et al. Nordic Society of Paediatric Haematology and Oncology (NOPHO), Swedish Cytogenetic Leukaemia Study Group (SCLSG), NOPHO Leukaemia Cytogenetic Study Group (NLCSG), Cytogenetic abnormalities in childhood acute myeloid leukaemia: a Nordic series comprising all children enrolled in the NOPHP- 93-AML trial between 1993 and 2001. Br J Haematol 2003; 121: 566-77.

2. Yin CC, Cortes J, Barkoh B, Hayes K, et al. t(3;21) (q26;q22) in myeloid leukemia an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy. Cancer 2006; 106: 1730-8.

3. Khalidi HS, Medeiros J, Chang KL, Brynes RK, et al. The immunophenotype of adult acute myeloid. High frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. Am J Clin Pathol 1998; 109: 211-20.

4. Raimondi SC, Chang MN, Ravindranath Y, Behm FG, et al. Chromosomal abnormalities in 478 children with acute myeloid leukaemia: clinical characteristics and treatment outcome a cooperative pediatric oncology group study-POG 8821. Blood 1999; 94: 3707-16.